Work

Phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer (072)

Year: 2022

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(22)01289-6

Authors: Panagiotis Konstantinopoulos, Elizabeth Lee, Niya Xiong, Carolyn Krasner, Susana Campos, Joyce Liu, Alexi Wright, Hannah Sawyer, Madeline Polak, Su-Chun Cheng, Ursula Matulonis, Neil Horowitz, Sara Bouberhan, Richard Penson, Oladapo Yeku, Cesar Castro, Meghan Shea

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4297770846

FWCI: 0.65

Cites:

Cited by: 4

Related to: 10